Table 1.
Summary of pancreatic giant cell tumors described between 2002 and 2012, showing treatment and outcome.
| Year of publication | Author | Number of cases | Type of pancreatic giant cell cancer | Treatment | Outcome |
|---|---|---|---|---|---|
| 200213 | Shiozawa | 32 | Undifferentiated osteoclast like giant cell | Pancreatic Resection | Mean survival of 20.4 months |
| 20049 | Zou | 19 | GCT | Inoperable-14, PD-2, Pancreatic resection-3 | Mean survival of 4 months |
| 200414 | Loya | 1 | Mixed | PD | Alive at 3 years |
| 200415 | Osaka | 1 | OGCT | DP + S + TG | Alive at 3 years |
| 200516 | Ezenekwe | 1 | Mixed | Inoperable | |
| 20063 | Lukas | 2 | Inoperable | ||
| 200617 | Sautot-Vial | 1 | OGCT | PD | Overall 26 months of survival |
| 200618 | Tezuka | 1 | Intraductal OGCT | PD | Alive without recurrence at 22 months |
| 200619 | Bauditz | 1 | Mixed | Chemotherapy | Continued CT at 13 months |
| 200620 | Janes | 1 | OGCT | Palliation | Died at 7 months |
| 200821 | Layfield | 6 | PGCT-5, OGCT-1 | PD-1 Unresectable-3 Metastasis-2 |
Alive at 3 months Died at 3 months Lost follow up |
| 200922 | Moore | 5 | PGCT-3, OGCT-1 Mixed-1 |
Palliation-3, PD + hepatic segmentectomy + RFA + RT PD + chemotherapy |
Died at mean of 12.3 weeks-3 Alive at 18 months-1 Alive at 13 months-1 after resection |
| 200923 | Marosh | 1 | Undifferentiated GCT | PD + lymph node resection | Died 12 months after resection |
| 20091 | Burkadze | 1 | OGCT | Pancreatic resection | Free of disease after 4 years |
| 201024 | Rauramaa | 1 | OGCT | PD | Free of disease after 1.5 years of resection |
| 20102 | Athanasios | 1 | Pleomorphic GCT | En-bloc resection | Recurrence at 4 months |
| 20105 | Singhal | 1 | OGCT | Pancreatic resection | – |
| 20116 | Rustagi | 1 | PGCT | PD | No recurrence after 20 months |
| 201125 | Wada | 1 | OGCT | Pancreatic resection | Died after 4 months |
| 201126 | Schaffner | 1 | OGCT | – | Pulmonary metastasis |
| 201227 | Sivanandham | 1 | OGCT | – | – |